These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 29330310)
41. Measuring Adolescent Human Papillomavirus Vaccine Coverage: A Match of Sexually Transmitted Disease Clinic and Immunization Registry Data. Pathela P; Jamison K; Papadouka V; Kabir R; Markowitz LE; Dunne EF; Schillinger JA J Adolesc Health; 2016 Dec; 59(6):710-715. PubMed ID: 27671357 [TBL] [Abstract][Full Text] [Related]
42. Policy and socio-cultural differences between cantons in Switzerland with high and low adolescent vaccination coverage for hepatitis B and HPV. Masserey Spicher V; Weiss MG Vaccine; 2019 Dec; 37(52):7539-7546. PubMed ID: 31630937 [TBL] [Abstract][Full Text] [Related]
43. [Knowledge of Human Papillomavirus Infection and the Possibilities for Prevention among 13- to 21-Year-Old Students from Fulda, Hessen]. Stumm C; Hahn D; Heberlein I; Doherr F; Hofmann W Gesundheitswesen; 2017 May; 79(5):399-406. PubMed ID: 25622213 [No Abstract] [Full Text] [Related]
44. Strengthening HPV vaccination delivery: findings from a qualitative service evaluation of the adolescent girls' HPV vaccination programme in England. Paterson P; Mounier-Jack S; Saliba V; Yarwood J; White J; Ramsay M; Chantler T J Public Health (Oxf); 2021 Apr; 43(1):189-196. PubMed ID: 31219155 [TBL] [Abstract][Full Text] [Related]
45. Actions improving HPV vaccination uptake - Results from a national survey in Italy. Giambi C; Del Manso M; D'Ancona F; De Mei B; Giovannelli I; Cattaneo C; Possenti V; Declich S; Vaccine; 2015 May; 33(21):2425-31. PubMed ID: 25869895 [TBL] [Abstract][Full Text] [Related]
46. Inequalities in the uptake of human papillomavirus vaccination: a systematic review and meta-analysis. Fisher H; Trotter CL; Audrey S; MacDonald-Wallis K; Hickman M Int J Epidemiol; 2013 Jun; 42(3):896-908. PubMed ID: 23620381 [TBL] [Abstract][Full Text] [Related]
48. Race, ethnicity, and income factors impacting human papillomavirus vaccination rates. Jeudin P; Liveright E; Del Carmen MG; Perkins RB Clin Ther; 2014 Jan; 36(1):24-37. PubMed ID: 24417783 [TBL] [Abstract][Full Text] [Related]
49. School-based vaccination programmes: An evaluation of school immunisation delivery models in England in 2015/16. Tiley K; Tessier E; White JM; Andrews N; Saliba V; Ramsay M; Edelstein M Vaccine; 2020 Mar; 38(15):3149-3156. PubMed ID: 31980192 [TBL] [Abstract][Full Text] [Related]
50. County-Level Factors Associated With HPV Vaccine Coverage Among 11-Year-Olds to 12-Year-Olds Living in Florida in 2019. Osegueda ER; Chi X; Hall JM; Vadaparampil ST; Christy SM; Staras SAS J Adolesc Health; 2023 Jan; 72(1):130-137. PubMed ID: 36244897 [TBL] [Abstract][Full Text] [Related]
51. Socioeconomic inequalities to accessing vaccination against human papillomavirus in France: Results of the Health, Health Care and Insurance Survey, 2012. Guthmann JP; Pelat C; Célant N; Parent du Chatelet I; Duport N; Rochereau T; Lévy-Bruhl D Rev Epidemiol Sante Publique; 2017 Apr; 65(2):109-117. PubMed ID: 28238476 [TBL] [Abstract][Full Text] [Related]
52. Strengthening the Effectiveness of National, State, and Local Efforts to Improve HPV Vaccination Coverage in the United States: Recommendations From the National Vaccine Advisory Committee. Approved by the National Vaccine Advisory Committee on June 25, 2018 Public Health Rep; 2018; 133(5):543-550. PubMed ID: 30091942 [TBL] [Abstract][Full Text] [Related]
53. Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia. Watson M; Shaw D; Molchanoff L; McInnes C Aust N Z J Public Health; 2009 Aug; 33(4):365-70. PubMed ID: 19689598 [TBL] [Abstract][Full Text] [Related]
54. School-based vaccination program against HPV and Hepatitis B: A longitudinal analysis of vaccine coverage between 2015 and 2021 in Quebec. Dionne M; Sauvageau C; Kiely M; Dahhou M; Hamel D; Rathwell M; Bandara T; Neudorf C; Dubé È Vaccine; 2024 Jan; 42(1):17-23. PubMed ID: 38044245 [TBL] [Abstract][Full Text] [Related]
55. Evaluation of human papilloma virus (HPV) vaccination strategies and vaccination coverage in adolescent girls worldwide. Owsianka B; Gańczak M Przegl Epidemiol; 2015; 69(1):53-8, 151-5. PubMed ID: 25862448 [TBL] [Abstract][Full Text] [Related]
56. Continuing reductions in HPV 16/18 in a population with high coverage of bivalent HPV vaccination in England: an ongoing cross-sectional study. Mesher D; Panwar K; Thomas SL; Beddows S; Soldan K BMJ Open; 2016 Feb; 6(2):e009915. PubMed ID: 26868944 [TBL] [Abstract][Full Text] [Related]
57. Trends and factors associated with receipt of human papillomavirus (HPV) vaccine in private, public, and alternative settings in the United States. White MC; Osazuwa-Peters OL; Abouelella DK; Barnes JM; Cannon TY; Watts TL; Adjei Boakye E; Osazuwa-Peters N Vaccine; 2024 Sep; 42(22):126036. PubMed ID: 38876838 [TBL] [Abstract][Full Text] [Related]
58. Human Papillomavirus Vaccination Uptake before and after the Affordable Care Act: Variation According to Insurance Status, Race, and Education (NHANES 2006-2014). Corriero R; Gay JL; Robb SW; Stowe EW J Pediatr Adolesc Gynecol; 2018 Feb; 31(1):23-27. PubMed ID: 28756028 [TBL] [Abstract][Full Text] [Related]
59. Examining inequalities in the uptake of the school-based HPV vaccination programme in England: a retrospective cohort study. Fisher H; Audrey S; Mytton JA; Hickman M; Trotter C J Public Health (Oxf); 2014 Mar; 36(1):36-45. PubMed ID: 23620542 [TBL] [Abstract][Full Text] [Related]
60. Implementation of Routine HPV Vaccination in the Management of Recurrent Respiratory Papillomatosis. Yiu Y; Fayson S; Smith H; Matrka L Ann Otol Rhinol Laryngol; 2019 Apr; 128(4):309-315. PubMed ID: 30595025 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]